Lisa Suddreth
Psychiatric/Mental Health · Gastonia, NCNPI 1033434519
Payments from drug & device makers
Across 1,203 payments — averaging $92.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$75K
- Otsuka America Pharmaceutical, Inc.$13K
- Axsome Therapeutics, Inc.$10K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Novo Nordisk$998
- plus $9K from 30 others
What the payments were for
- Consulting fees$8,2257%
- Speaking & faculty fees$70,99964%
- Travel & lodging$14,30113%
- Food & beverage$17,59016%
- Education$1090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$71,726
- ABILIFY MAINTENA$11,397
- Auvelity$9,448
- ABILIFY ASIMTUFII$3,493
- LYBALVI$1,415
- ARISTADA$479
- Wegovy$455
- CAPLYTA$364
- COBENFY$149
- INVEGA SUSTENNA$125
- ARISTADA INITIO$120
- ONGENTYS$114
- INGREZZA$114
- AUSTEDO$112
- UZEDY$109
- LATUDA$100
How this compares
$111,224 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 17 | $17,244 |
| BelsomraSuvorexant | 19 | $8,441 |
| Lurasidone Hcl | 22 | $7,444 |
| Duloxetine Hcl | 95 | $2,379 |
| Lamotrigine | 166 | $2,190 |
| Aripiprazole | 59 | $1,964 |
| Bupropion XlBupropion Hcl | 112 | $1,889 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $1,889 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 47 | $1,639 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $1,320 |
| Gabapentin | 47 | $1,019 |
| Trazodone Hcl | 67 | $963 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $952 |
| Methylphenidate Hcl | 52 | $936 |
| Clonazepam | 171 | $786 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $582 | $17,24417 claims |
| MerckBelsomra | $21 | $8,44119 claims |
| Almatica Pharma LLCSertraline Hcl | $323 | $26113 claims |
| Lilly USA, LLCOlanzapine | $17 | $8312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Gastonia
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
- Karen OckenholtStatesville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.